Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen
Authors:
- 1 February 1995
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 34 (2) , 91-109
Abstract
During 1985–1990 the U.S. National Cancer Institute (NCI) phased out its murine leukemia P388 anticancer drug screening program and developed as the replacement a new in vitro primary screen based upon a diverse panel of human tumor cell lines. For each substance tested, the screen generates a remarkably reproducible and characteristic profile of differential in vitro cellular sensitivity, or lack thereof, across the 60 different cell lines comprising the panel. Several investigational approaches to display, analysis, and interpretation of such profiles and databases, derived from the testing of tens of thousands of substances during the past 4–5 years since the NCI screen became fully operational, have been explored. A variety of useful, practical applications of the in vitro screen have become apparent. As these applications continue to evolve, they are proving to be complementary to diverse other anticancer screening and drug discovery strategies being developed or pursued elsewhere. Reviewed herein are some practical considerations and selected specific examples, particularly illustrating research applications of the NCI screen that may be more broadly applicable to the search for new anticancer drug development leads with novel profiles of antitumor activity and/or mechanisms of action. © 1995 Wiley‐Liss, Inc. This article is a US Government work and, as such, is in the public domain in the United States of America.Keywords
This publication has 27 references indexed in Scilit:
- Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.Journal of Clinical Investigation, 1995
- Use of the Kohonen Self-organizing Map to Study the Mechanisms of Action of Chemotherapeutic AgentsJNCI: Journal of the National Cancer Institute, 1994
- Isolation and Structure/Activity Features of Halomon-Related Antitumor Monoterpenes from the Red Alga Portieria hornemanniiJournal of Medicinal Chemistry, 1994
- Editorial - "Mean Graphs" of NCI Screening DataJournal of Medicinal Chemistry, 1994
- Cellular Uptake as a Determinant of Cytotoxicity of Quarternalized Ellipticines to Human Brain Tumor CellsBiochemical and Biophysical Research Communications, 1994
- Predictive statistics and artificial intelligence in the U.S. National Cancer Institute's drug discovery program for cancer and AIDSStem Cells, 1994
- Isolation and structure of the powerful human cancer cell growth inhibitors spongistatins 4 and 5 from an African Spirastrella spinispirulifera(porifera)Journal of the Chemical Society, Chemical Communications, 1993
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE AlgorithmJNCI: Journal of the National Cancer Institute, 1989
- Establishment and characterization of a cell line of human breast carcinoma origin1979